These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 592561)

  • 21. Short communication: Toxicokinetics of ochratoxin A in dairy ewes and carryover to milk following a single or long-term ingestion of contaminated feed.
    Boudra H; Saivin S; Buffiere C; Morgavi DP
    J Dairy Sci; 2013 Oct; 96(10):6690-6. PubMed ID: 23972496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis of 14C-ochratoxin A and 14C-ochratoxin B and a comparative study of their distribution in rats using whole body autoradiography.
    Breitholtz-Emanuelsson A; Fuchs R; Hult K; Appelgren LE
    Pharmacol Toxicol; 1992 Apr; 70(4):255-61. PubMed ID: 1608909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics and metabolism of bisoprolol-14C in three animal species and in humans.
    Bühring KU; Sailer H; Faro HP; Leopold G; Pabst J; Garbe A
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S21-8. PubMed ID: 2439794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Studies on the metabolic fate of 14C-rokitamycin. I. Absorption, distribution, metabolism and excretion in rats].
    Suzuki T; Sakai A; Morishita M; Muranishi S
    Jpn J Antibiot; 1987 Mar; 40(3):499-518. PubMed ID: 3613074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tissue distribution and excretion of CDRI-81/470 in rats.
    Nagaraja NV; Singh SK; Paliwal JK; Gupta RC
    J Pharm Pharmacol; 2000 Oct; 52(10):1257-63. PubMed ID: 11092570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolism and excretion of a novel antianxiety drug candidate, CP-93,393, in Long Evans rats. Differentiation of regioisomeric glucuronides by LC/MS/MS.
    Prakash C; Soliman V
    Drug Metab Dispos; 1997 Nov; 25(11):1288-97. PubMed ID: 9351906
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
    Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
    Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on metabolism of tripamide. III. Metabolic fate of 14C-tripamide in rats and rabbits.
    Horie T; Ohno T; Kinoshita K
    Jpn J Pharmacol; 1982 Dec; 32(6):1041-9. PubMed ID: 7161960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pre-clinical pharmacokinetics of the cyclooxygenase-inhibiting nitric oxide donor (CINOD) AZD3582.
    Fagerholm U; Breuer O; Swedmark S; Hoogstraate J
    J Pharm Pharmacol; 2005 May; 57(5):587-97. PubMed ID: 15901348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disposition of a low dose of 14C-bisphenol A in male rats and its main biliary excretion as BPA glucuronide.
    Kurebayashi H; Betsui H; Ohno Y
    Toxicol Sci; 2003 May; 73(1):17-25. PubMed ID: 12700409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolism of triamterene in the rat.
    Kau ST; Sastry BV; Alvin JD; Bush MT
    Drug Metab Dispos; 1975; 3(5):345-51. PubMed ID: 241615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Absorption, distribution and excretion of nilvadipine, a new dihydropyridine calcium antagonist, in rats and dogs.
    Tokuma Y; Fujiwara T; Noguchi H
    Xenobiotica; 1987 Nov; 17(11):1341-9. PubMed ID: 3433803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of nimodipine. I. Communication: absorption, concentration in plasma and excretion after single administration of [14C]nimodipine in rat, dog and monkey.
    Maruhn D; Siefert HM; Weber H; Rämsch K; Suwelack D
    Arzneimittelforschung; 1985; 35(12):1781-6. PubMed ID: 4096729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Absorption, distribution and excretion of lacidipine, a dihydropyridine calcium antagonist, in rat and dog.
    Pellegatti M; Grossi P; Ayrton J; Evans GL; Harker AJ
    Xenobiotica; 1990 Aug; 20(8):765-77. PubMed ID: 2219960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of the absorption, distribution, and elimination of melphalan in the dog.
    Furner RL; Brown RK; Duncan G
    Cancer Treat Rep; 1977 Dec; 61(9):1637-46. PubMed ID: 597816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distribution of 14C-ochratoxin A and 14C-ochratoxin B in rats: a comparison based on whole-body autoradiography.
    Breitholtz Emanuelsson A; Fuchs R; Hult K; Appelgren LE
    IARC Sci Publ; 1991; (115):201-3. PubMed ID: 1820334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disposition of the new antirheumatic agent ethyl 4-(3,4-dimethoxyphenyl)- 6,7-dimethoxy-2-(1,2,4-triazol-1-ylmethyl)quinoline-3-carboxylate (TAK-603) in rats and dogs.
    Tagawa Y; Kiyota Y; Yoshimura Y; Motohashi M; Tanayama S
    Arzneimittelforschung; 1998 Jul; 48(7):750-7. PubMed ID: 9706376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intestinal absorption and secretion of ochratoxin A in the rat.
    Kumagai S; Aibara K
    Toxicol Appl Pharmacol; 1982 Jun; 64(1):94-102. PubMed ID: 7112589
    [No Abstract]   [Full Text] [Related]  

  • 40. Immunohistochemical fate of ochratoxin A in mice.
    Lee SC; Beery JT; Chu FS
    Toxicol Appl Pharmacol; 1984 Feb; 72(2):218-27. PubMed ID: 6364453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.